Donald Trump has hit steel and aluminium with tariffs and the US is eyeing Australia's agriculture and pharmaceutical ...

The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid.

Alnylam Pharmaceuticals gains FDA approval for Amvuttra in ATTR-CM, boosting revenue prospects. Click here to read an ...

Unicameral bills winning a priority bill designation will move ahead of others for first-round floor debate if they advance from committee before the Legislature adjourns its 90-day 2025 session.

President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut ...

Optum Rx's new cost-based program uses an internal algorithm that leverages multiple available industry data sources, such as ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

We recently compiled a list of the 12 Stocks Under $10 With High Upside Potential. In this article, we are going to take a ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

DUBLIN and BRIDGEWATER, N.J., March 12, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced financial results for the fourth quarter of 2024 and provided a review of fourth ...